Curtis Holt is currently the Lead Clinical Scientist for Antimicrobial Resistance at Biogen, a position assumed in 2024. Previously, they served as a Principal Medical Scientist at Gilead Sciences from 2020 to 2024 and held a significant role as a Clinical Professor at UCLA Medical Center from 1991 to 2020. Curtis earned a BS in biology from the University of California, San Diego, and a Doctor of Pharmacy from the University of California, San Francisco, where they also completed a clinical residency and a fellowship in infectious diseases. Their research focuses on drug monitoring in transplant recipients and they have actively published numerous papers and book chapters in related fields.
This person is not in the org chart
This person is not in any teams
This person is not in any offices